Endoscopy Devices Market Size & Outlook, 2026-2034

Endoscopy Devices Market Size

The endoscopy devices market size was valued at USD 61.91 billion in 2025 and is projected to reach USD 84.52 billion by 2034, growing at a CAGR of 3.56% during the forecast period (2026-2034). Initially, the endoscopy devices were used in specialized hospital settings, but currently their adoption has expanded across hospitals, ambulatory surgical centers, and diagnostic clinics, Thus, the market is expected to witness strong growth in the coming years.

Key Market Insights

• North America dominated the market with the largest market share of 40.68% in 2025.
• Asia Pacific is expected to be the fastest-growing region during the forecast period at a CAGR of 5.56%.
• By type, the endoscopes segment dominated the market with the largest share of 43.56% in 2025.
• By end use, the hospitals segment is expected to grow rapidly during the forecast period at a CAGR of 4.45%.
• The US endoscopy devices market size was valued at USD 21.74 billion in 2025 and is projected to reach USD 22.44 billion in 2026.

To get more insights about this report Download Free Sample Report

Endoscopy Devices Market Trends

Transition from diagnostic visualization to procedure-based therapeutic endoscopy

The market is witnessing a shift from internal visualization tools to platforms that enable complete interventions during a single procedure. Several clinical guidelines that are issued by national cancer institutes and gastroenterology societies emphasize using endoscopic resection and closure as well as bleeding control in order to avoid open surgery. Various public health systems increasingly support endoscopic therapy for reducing surgical admissions. Such transition supports in reshaping care pathways from diagnosis followed by surgery to diagnosis with immediate intervention, increasing demand for multifunctional endoscopy systems across gastrointestinal as well as pulmonary applications, which further enhances the market growth.

Shift from manually documented workflows to digitally traceable endoscopy systems

Endoscopy units are shifting from paper-based documentation to digitally traceable device workflows. Various healthcare accreditation bodies and several infection prevention agencies recommend the traceability of scopes and reprocessing cycles as well as patient linkage. Such a shift supports compliance monitoring, infection surveillance, and procedural accountability. Hospitals are integrating endoscopy devices with digital tracking platforms to meet regulatory expectations, moving the market from isolated hardware usage to data-integrated procedural ecosystems.

Market Drivers

Expansion of organized cancer screening programs boosts market growth

National colorectal and gastrointestinal cancer screening initiatives continue to expand eligibility and procedural volume, which further enhances the market growth as public health agencies promote endoscopy as the primary modality for early detection and lesion removal. As screening participation rises, healthcare systems require high-capacity endoscopy infrastructure to manage recurring examinations. This driver sustains long-term market growth, as screening programs are embedded within national cancer control frameworks rather than discretionary healthcare spending.

Policy focus on reducing surgical burden and inpatient stays drives adoption of endoscopy devices

Government healthcare systems are prioritizing minimally invasive care models to reduce hospitalization duration and surgical costs. Endoscopy enables internal access without open procedures, supporting same-day discharge and lower postoperative complications. Health system reforms emphasize shifting procedures from operating theaters to outpatient settings, which further supports the wider deployment of endoscopy devices across hospitals and ambulatory care centers.

Market Restraint

Operational complexity and infection prevention requirements restrains market

Endoscopy devices require multi-step cleaning, disinfection, and monitoring to meet infection control standards, which restrains market growth. Public health advisories and hospital safety audits highlight challenges in maintaining consistent reprocessing quality. Facilities must invest in trained staff, dedicated infrastructure, and compliance documentation. These operational demands slow adoption in resource-constrained settings and limit rapid scale-up of endoscopy services despite rising procedural demand.

Market Opportunity

Decentralization of endoscopy services into secondary and district healthcare facilities offers growth opportunities

Decentralization of endoscopy services into secondary and district healthcare facilities helps in market expansion as health ministers and public healthcare organizations are expanding both diagnostic and procedural services beyond the tertiary hospitals. Various endoscopy devices align with this factor, as they are designed for simplified maintenance and outpatient use. They are further supporting the deployment of endoscopy systems at district healthcare centers to enhance early disease detection and minimize referral delays. Collectively, these developments create strong opportunities for market penetration through volume-driven adoption in secondary care settings while simultaneously advancing national public health access and equity objectives.

Technological Landscape

• EndoBRAIN and EndoBRAIN Plus platforms offered by Olympus apply deep learning models to support the colorectal lesion assessment during the colonoscopy.
• GI Genius System by Medtronic plc tracks the visual patterns in the mucosal surfaces and alerts the clinicians during the real-time procedures.
• Fujifilm integrates AI-based visualization tools within its endoscopy systems to support procedural planning, documentation, and post procedure review.

Regional Analysis

The endoscopy devices market in North America had a market share of 40.68% in 2025 due to structured national screening frameworks and standardized diagnostic pathways. The region has a robust infrastructure and a willingness toward endoscopy procedures. For instance, the uptake of a routine colorectal cancer screening is promoted by the Centers for Disease Control and Prevention. This has resulted in increasing volumes of colonoscopy and sigmoidoscopy procedures among adults above 45 years of age. The US FDA also promotes the adoption of advanced devices with a centralized device clearance system. The Ontario Ministry of Health in Canada supports large-scale endoscopic screening under initiatives such as ColonCancerCheck. These measures show high adoption of screening programs in the region.

The US leads the North American market. The country has robust healthcare coverage, as witnessed by Medicare and Medicaid, which encourages diagnostics and screening. Institutions such as the National Cancer Institute have integrated endoscopy into national cancer control strategies. This reinforces the upgrades required by healthcare facilities for endoscopy integration across public and private networks.

Asia Pacific's Market Trends

Asia Pacific is expected to have a considerable growth of 5.56% during the forecast period due to expanding diagnostic access and government investment in secondary healthcare infrastructure. Countries across the region are prioritizing early disease identification to reduce long-term treatment costs. National health authorities are increasing procurement of endoscopy systems for gastrointestinal and pulmonary diagnostics within public hospitals, supporting accelerated adoption across urban and semi-urban areas.

India leads growth in the Asia Pacific region through public healthcare expansion programs, such as the Ministry of Health and Family Welfare supporting diagnostic capacity building under the Ayushman Bharat program. In addition, endoscopy services are increasingly deployed in district hospitals and medical colleges, particularly for gastrointestinal cancer screening and tuberculosis-related respiratory evaluation, expanding procedural access beyond tertiary centers, which further drives the market growth.

European Market Trends

Europe demonstrates stable growth driven by harmonized medical device governance and national screening policies. The European Commission supports cancer screening initiatives under Europe’s Beating Cancer Plan, encouraging member states to expand endoscopy-based diagnostics. Germany and France continue to modernize hospital endoscopy suites to align with infection control and patient safety frameworks.

Spain is expected to be a dominant market in Europe due to targeted hospital modernization initiatives led by the Spanish Ministry of Health. Public funding supports expansion of digestive disease screening programs, increasing demand for gastrointestinal endoscopy systems across regional health services.

Latin American Market Trends

Latin America is experiencing gradual expansion as public healthcare systems strengthen diagnostic capabilities. Ministries of health across the region are integrating endoscopy into national cancer detection strategies, supporting adoption in tertiary care hospitals and academic medical centers.

Brazil records steady growth supported by cancer screening initiatives under the Brazilian Ministry of Health. In addition, the Unified Health System promotes wider access to gastrointestinal endoscopy, particularly for gastrointestinal cancer detection, increasing procedural volumes in public hospitals, which hence enhances the market growth.

Middle East and Africa

In the Middle East and Africa, endoscopy devices are used as essential diagnostic and interventional tools to support minimally invasive examination and treatment of gastrointestinal, respiratory, urological, and gynecological conditions. These devices are increasingly adopted across public hospitals and academic medical centers to strengthen in-country diagnostic capacity, reduce dependence on surgical procedures, and improve access to early disease detection in line with national healthcare development strategies across the region.

In South Africa, endoscopy devices are used for minimally invasive diagnosis and treatment of gastrointestinal and respiratory conditions across public and academic healthcare facilities. Their adoption supports early disease detection and procedural management within the national healthcare system. For example, public hospitals operating under the National Department of Health of South Africa utilize endoscopy services for cancer screening and tuberculosis-related airway evaluation, strengthening diagnostic capacity within state-funded healthcare institutions.

Type Insights

The endoscopes segment accounted for the largest market share of 43.56% in 2025, due to widespread adoption of reusable endoscopes across the gastrointestinal, urology, gynecology, orthopedic, and respiratory procedures. Hospitals and outpatient facilities continue to rely on rigid laparoscopes, arthroscopes, bronchoscopes, and gastrointestinal endoscopes due to established clinical protocols, longer device life cycles, and compatibility with existing visualization systems, which sustains stable procurement volumes.

The flexible endoscopes segment is projected to be the fastest growing, recording a growth rate of 4.13% during the forecast period, driven by increasing preference for minimally invasive diagnostics and therapeutic procedures. Rising use of flexible colonoscopes, gastroscopes, capsule endoscopes, and robot-assisted platforms supports growth as healthcare systems expand screening programs and outpatient-based endoscopic interventions.

End Use Insights

The outpatient facilities dominated the market as endoscopy services increasingly shifted away from inpatient settings. Cost containment policies and procedural efficiency encourage deployment of endoscopy systems in ambulatory centers, reinforcing dominance.

Hospitals represent the fastest-growing end-use segment, with a growth rate of 4.45%, supported by expanding procedure volumes, advanced endoscopy suites, and integration of complex therapeutic endoscopic interventions within hospital settings. These factors are expected to propel the endoscopy devices market growth throughout the forecast period.

Table: Endoscopy Devices Market Segments

Regulatory Bodies Governing Endoscopy Devices Market

List of Key and Emerging Players in Endoscopy Devices Market

1. Olympus Corporation
2. Boston Scientific Corporation
3. PENTAX Medical
4. FUJIFILM Holdings Corporation
5. Karl Storz GmbH & Co., KG
6. Stryker
7. Medtronic
8. Ambu A/S
9. Activ Surgical
10. Aesculap, Inc.
11. Auris Health
12. Conmed Corporation
13. R. Bard, Inc.
14. Fujifilm Holdings
15. Hologic
16. Medtronic plc
17. Olympus Corporation
18. Pentax Medical
19. Smith & Nephew
20. BiBBInstruments

To get more findings about this report Download Market Share

Latest News on Key and Emerging Players